Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 8
1962 5
1963 9
1964 1
1965 7
1966 5
1967 11
1968 14
1969 18
1970 15
1971 14
1972 16
1973 20
1974 10
1975 11
1976 4
1977 7
1978 19
1979 17
1980 13
1981 28
1982 30
1983 22
1984 29
1985 32
1986 25
1987 34
1988 34
1989 31
1990 35
1991 48
1992 45
1993 65
1994 62
1995 59
1996 56
1997 59
1998 55
1999 67
2000 51
2001 61
2002 53
2003 35
2004 43
2005 39
2006 46
2007 46
2008 57
2009 55
2010 59
2011 67
2012 83
2013 71
2014 59
2015 73
2016 51
2017 72
2018 70
2019 91
2020 88
2021 104
2022 107
2023 108
2024 129
2025 115
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,676 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: a multicentre REVEAL cohort study.
Miyake H, Okazaki A, Matsuda S, Masuda Y, Kotani T, Hatta M, Shiomi M, Watanabe R, Hashimoto M, Oka H, Sumitomo S, Jo K, Fujiki Y, Yamamoto W, Taniguchi T, Shoji M, Manabe A, Hiwa R. Miyake H, et al. Among authors: masuda y. Mod Rheumatol. 2025 Dec 12:roaf124. doi: 10.1093/mr/roaf124. Online ahead of print. Mod Rheumatol. 2025. PMID: 41384758
Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.
Fujino K, Maruyama R, Marutsuka T, Iwatani K, Aoki M, Suetsugu T, Takenaka M, Saeki S, Sakata S, Motooka Y, Masuda Y, Yoshimoto K, Ikeda K, Suzuki M. Fujino K, et al. Among authors: masuda y. J Thorac Dis. 2025 Nov 30;17(11):10209-10219. doi: 10.21037/jtd-2025-1518. Epub 2025 Nov 26. J Thorac Dis. 2025. PMID: 41376950 Free PMC article.
Detection of interictal epileptiform discharges using multiple bilateral insertions of a newly developed microcatheter-compatible endovascular electroencephalogram electrode: A clinical feasibility trial.
Araki K, Masuda Y, Fujimoto A, Nishimura M, Hosoo H, Ishida H, Enokizono T, Kawai K, Ishikawa E, Matsumaru Y. Araki K, et al. Among authors: masuda y. Epilepsia Open. 2025 Dec 6. doi: 10.1002/epi4.70166. Online ahead of print. Epilepsia Open. 2025. PMID: 41351426 Free article.
Differences in contributing factors to diagnostic errors between physicians and allied health professionals: a nationwide analysis in Japan.
Shimizu I, Shikino K, Harada Y, Kurihara M, Tanaka K, Masuda Y, Watanuki S, Ohishi Y, Nakazato T, Ishizuka K, Komatsu M, Miyagami T, Nishizawa T, Nishimura R, Oshita T, Suzuki T, Shimizu T. Shimizu I, et al. Among authors: masuda y. BMJ Open Qual. 2025 Nov 24;14(4):e003419. doi: 10.1136/bmjoq-2025-003419. BMJ Open Qual. 2025. PMID: 41290260 Free PMC article.
2,676 results